| Dataset | DGIdb Drug Targets 2026 |
| Category | physical interactions |
| Type | drug |
| Description | Nadolol is a diastereoisomeric mixture consisting of equimolar amounts of the four possible 2,3-cis-isomers of 5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol. (Chemical Entities of Biological Interest Ontology, CHEBI_7444) |
| External Link | https://dgidb.org/results?searchType=drug&searchTerms=NADOLOL |
| Similar Terms | |
| Downloads & Tools |
8 interacting proteins for the NADOLOL drug from theDGIdb Drug Targets 2026 dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| SLCO1A2 | solute carrier organic anion transporter family, member 1A2 | 1.10275 |
| GRK4 | G protein-coupled receptor kinase 4 | 0.472607 |
| LPL | lipoprotein lipase | 0.413531 |
| ADRB1 | adrenoceptor beta 1 | 0.345638 |
| GRK5 | G protein-coupled receptor kinase 5 | 0.245056 |
| ADRB2 | adrenoceptor beta 2, surface | 0.225562 |
| ADRB3 | adrenoceptor beta 3 | 0.106718 |
| ADRA2C | adrenoceptor alpha 2C | 0.0537927 |